日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

通过靶向耐药细胞的选择性优势来延长肺癌对 EGFR 抑制剂的反应时间

Brunet, Lisa; Alexandre, David; Lee, Jiyoung; Blanquer-Rosselló, Maria Del Mar; Bracquemond, David; Guernet, Alexis; Chhouri, Houssein; Goupil, Mathilde; Kherrouche, Zoulika; Arabo, Arnaud; Mancini, Maicol; Cartier, Dorthe; Yao, Shen; Godefroy, David; Dehedin, Julie; Li, Jian-Rong; Duparc, Céline; Jamme, Philippe; Vinchent, Audrey; Bérard, Caroline; Tulasne, David; Arena, Sabrina; Bardelli, Alberto; Cheng, Chao; Cho, Byoung Chul; Wurtz, Olivier; Coulouarn, Cédric; Maraver, Antonio; Aaronson, Stuart A; Cortot, Alexis B; Anouar, Youssef; Grumolato, Luca

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.

在遗传性乳头状肾细胞癌中发现的具有激活 N 叶突变的 MET 变体仍然需要配体刺激

Guérin Célia, Vinchent Audrey, Fernandes Marie, Damour Isabelle, Laratte Agathe, Tellier Rémi, Estevam Gabriella O, Meneboo Jean-Pascal, Villenet Céline, Descarpentries Clotilde, Fraser James S, Figeac Martin, Cortot Alexis B, Rouleau Etienne, Tulasne David

COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer

COMPOSIT 研究:评估奥希替尼联合靶向疗法治疗 EGFR 突变型非小细胞肺癌

Mehlman, Camille; Swalduz, Aurelie; Monnet, Isabelle; Morin, Clara; Wislez, Marie; Guisier, Florian; Curcio, Hubert; Du Rusquec, Pauline; Cortot, Alexis B; Gounant, Valerie; Abbar, Baptiste; Duchemann, Boris; Giroux-Leprieur, Etienne; Pierret, Thomas; Quilot, Fleur-Marie; Cadranel, Jacques; Fallet, Vincent

Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study

接受莫博替尼治疗的EGFR 20号外显子插入突变非小细胞肺癌患者的治疗模式和真实世界结果:EXTRACT研究

Liu, Geoffrey; Nyaw, Shi Feng; Mok, Tony S K; Curcio, Hubert; Cortot, Alexis B; Kam, Tsz Yeung; Descourt, Renaud; Chik, Yin Kwan; Cheema, Parneet; Gwinnutt, James M; Churchill, Eric N; Nyborn, Justin; Curran, Eileen; Savell, Alexandra; Yin, Yu; Chong, Katie; Tanaka-Chambers, Yuka; Kretz, Julian; Cadranel, Jacques

Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer

MARIPOSA-2 研究简明语言摘要:阿米伐他单抗联合化疗(可联合或不联合拉泽替尼)治疗非小细胞肺癌

Passaro, Antonio; Cortot, Alexis B; Gentzler, Ryan D; Reckamp, Karen L; Shah, Sujay; William, William Nassib; Cho, Byoung Chul

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy

MOMENT登记研究:接受全身治疗的携带MET外显子14跳跃突变的晚期非小细胞肺癌患者

Thomas, Michael; Christopoulos, Petros; Iams, Wade T; Mazières, Julien; Cortot, Alexis B; Peled, Nir; Minuti, Gabriele; Smit, Egbert F; Audhuy, Francois; Berghoff, Karin; Eggleton, S Peter; Fries, Frank; Hildenbrand, Maike; Liu, Peter; Mahmoudpour, Seyed Hamidreza; Menzel, Christoph; Oksen, Dina

Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial

Tepotinib治疗MET外显子14跳跃型非小细胞肺癌患者:VISION II期非随机临床试验的长期随访

Mazieres, Julien; Paik, Paul K; Garassino, Marina C; Le, Xiuning; Sakai, Hiroshi; Veillon, Remi; Smit, Egbert F; Cortot, Alexis B; Raskin, Jo; Viteri, Santiago; Wu, Yi-Long; Yang, James C H; Ahn, Myung-Ju; Ma, Rui; Zhao, Jun; O'Brate, Aurora; Berghoff, Karin; Bruns, Rolf; Otto, Gordon; Johne, Andreas; Felip, Enriqueta; Thomas, Michael

Response to Capmatinib in a MET Fusion-positive Cholangiocarcinoma

MET融合阳性胆管癌对卡马替尼的反应

Turpin, Anthony; Descarpentries, Clotilde; Grégoire, Valérie; Farchi, Olivier; Cortot, Alexis B; Jamme, Philippe

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers

非小细胞肺癌联合化疗和免疫治疗反应的组织分子因素

Marchal, Marine; Leroy, Vincent; Behal, Hélène; Dansin, Eric; Paris, Nicolas; Bordier, Soraya; Humez, Sarah; Escande, Fabienne; Gauvain, Clément; Cortot, Alexis B